SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-16-000877
Filing Date
2016-01-19
Accepted
2016-01-19 16:03:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A FOR ATARA BIOTHERAPEUTICS, INC. s13ga_011516-atarabio.htm SC 13G/A 53773
  Complete submission text file 0000904454-16-000877.txt   55368
Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542 609-683-5656
Domain Partners VIII, L.P. (Filed by) CIK: 0001465144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 161348347
SIC: 2836 Biological Products, (No Diagnostic Substances)